HALO384: A halo-based potency prediction algorithm for high-throughput detection of antimicrobial agents

Journal of Biomolecular Screening

Volumn 15, Issue 2, 2010, Pages 196-205

  Woehrmann, Marcos H ^a   Gassner, Nadine C ^b   Bray, Waiter M ^b   Stuart, Joshua M ^a   Lokey, Scott ^b  

^a University of California Santa Cruz   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Agar; Chemical library; Halo assay; High throughput; Optical density

Indexed keywords

2,4 DIAMINOQUINAZOLINE DERIVATIVE; ANTIINFECTIVE AGENT; CICLOPIROXOLAMINE; DISULFIRAM; RAPAMYCIN;

ACCURACY; ALGORITHM; ARTICLE; ASSAY; BACTERIUM; BACTERIUM CULTURE; DRUG POTENCY; FUNGUS CULTURE; GROWTH INHIBITION; HIGH THROUGHPUT SCREENING; LIQUID CULTURE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SCORING SYSTEM; VIBRIO CHOLERAE; YEAST;

ALGORITHMS; ANTI-INFECTIVE AGENTS; ANTIFUNGAL AGENTS; BIOLOGICAL ASSAY; CULTURE MEDIA; DRUG EVALUATION, PRECLINICAL; HIGH-THROUGHPUT SCREENING ASSAYS; INHIBITORY CONCENTRATION 50; MOLECULAR STRUCTURE; SACCHAROMYCES CEREVISIAE; SMALL MOLECULE LIBRARIES; TIME FACTORS; VIBRIO CHOLERAE;

BACTERIA (MICROORGANISMS); SACCHAROMYCES CEREVISIAE; VIBRIO CHOLERAE;

EID: 77949365801     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057109355060     Document Type: Article

References (9)

1. Gassner NC, Tamble CM, Bock JE, Cotton N, White KN, Tenney K, et al: Accelerating the discovery of biologically active small molecules using a high-throughput yeast halo assay. J Nat Prod 2007;70:383-390.
2. Yildiz FH, Schoolnik GK: Vibrio cholerae Ol El Tor: identification of a. gene cluster required for the rugose colony type, exopolysaccharide production, chlorine resistance, and biofilm !formation. Proc Natl Acad Sci USA 1999;96:4028-4033.
3. Balakin KV, Kozintsev AV, Kiselyov AS, Savchuk NP: Rational design approaches to chemical libraries for hit identification. Curr Drug Discov Technol 2006;3:49-65.
4. Zhang JH, Chung TD, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999;4:67-73.
5. Zembower J, Mishra R: 2,4-Diaminoquinazoline compound modulators of hepatocyte growth factor/c-met activity, and use in the treatment of cancer and other dysproliferative diseases. US Patent Application Publication, 2006.
6. De La Fuente R, Sonawane ND, Arumainayagam D, Verkman AS: Small, molecules with antimicrobial activity against E. coli and P. aeruginosa identified by high-throughput screening. Br J Pharmacol 2006;149:551-559.
7. Kim. ND, Yoon J, Kim. JH, Lee JT, Chon YS, Hwang M-K, et al: Putative therapeutic agents for the learning and memory deficits of people with Down syndrome. Bioorg Med Chem Lett 2006;16:3772-3776.
8. Wynne O, Johnson PD, Vickers R: Preparation of 2,4-diaminoquinazolines and analogs, and their use for the treatment of mycobacterial infections, especially tuberculosis. PCT International Application, 2008.
9. Koehn FE: High impact technologies for natural products screening. Prog Drug Res 2008;65:175, 177-210.